GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2024
GIANT BIOGENE: New Arrangements on Dissemination of Corporate Communications to Non-Registered Shareholders
GIANT BIOGENE: New Arrangements on Dissemination of Corporate Communications to Registered Shareholders
GIANT BIOGENE: Fourth Amended And Restated Memorandum And Articles of Association
GIANT BIOGENE: Special Dividend for the Year Ended 31 December 2023 (Updated)
GIANT BIOGENE: Final Dividend for the Year Ended 31 December 2023 (Updated)
GIANT BIOGENE: POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 13, 2024 AND PAYMENT OF FINAL DIVIDEND AND SPECIAL DIVIDEND
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2024
GIANT BIOGENE: Next Day Disclosure Return
GIANT BIOGENE: COMPLETION OFPLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OFNEW SHARES UNDER THE GENERAL MANDATE
GIANT BIOGENE: PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OFNEW SHARES UNDER THE GENERAL MANDATE
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2024
GIANT BIOGENE: FORM OF PROXY FOR USE AT 2023 ANNUAL GENERAL MEETINGTO BE HELD ON 13 JUNE 2024
GIANT BIOGENE: NOTICE OF ANNUAL GENERAL MEETING
GIANT BIOGENE: PROPOSED RE-APPOINTMENT OF AUDITORPROPOSED RE-ELECTION OF DIRECTORSPROPOSED GRANT OF GENERAL MANDATESTO REPURCHASE SHARES AND ISSUE SHARESPROPOSED DECLARATION AND DISTRIBUTION OFFINAL DIVIDENDS AND SPECIAL DIVIDENDSPROPOSED ADOPTION OF THE AMENDED AN
GIANT BIOGENE: 2023 Environmental, Social and Governance (ESG) Report
GIANT BIOGENE: ANNUAL REPORT 2023
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2024
GIANT BIOGENE: PROPOSED ADOPTION OF THE AMENDED AND RESTATEDMEMORANDUM AND ARTICLES OF ASSOCIATION
GIANT BIOGENE: Special Dividend for the Year Ended 31 December 2023
No Data